Live Breaking News & Updates on Rejection Prevention Market

Stay updated with breaking news from Rejection prevention market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Antibody-mediated Rejection Prevention Market is expected to be valued at US$ 89 million in 2023

The global antibody-mediated rejection prevention market is predicted to reach a valuation of US$ 89 million in 2023, with a compound annual growth rate (CAGR) of 16%, as per a recently published FMI report. Over the last decade, the complement system has emerged as an important constituent of the AMR market.Technol. ....

New York , United States , Hansa Biopharma , Asia Pacific , Eli Lilly , Bristol Myers Squibb Company , Data Monitoring Committee , Population Health Research Unit , Rejection Prevention Market , Teva Pharmaceutical Industries Ltd , Market Insights Inc , Pew Research Center , Viela Bio Inc , Greater New York Chamber , Research Council , Antibody Mediated Rejection Prevention , Talaris Therapeutics , Horizon Therapeutics , Viela Bio , Independent Data Monitoring Committee , Medical Research Council , Market Insights , Monoclonal Antibodies , Cysteine Protease Inhibitors , End User , Specialty Clinics ,